NM-2201 (also known as CBL-2201) is an indole-based synthetic cannabinoid that is believed to have similar properties to the closely related 5F-PB-22 and NNE1, both of which are full agonists and unselectively bind to low nanomolar affinity CB1 and CB2 receptors.